Here, we provide evidence that PRMT5 is a significant prognostic factor for MSS CRC progression and is an important DDR‐related epigenetic marker based on scRNA‐seq analysis of MSS CRC patients and bulk RNA‐seq analysis of paired MSS CRC tissues and NATs. Here, PRMT5 is linked to colorectal carcinoma.